Plerixafor 13C6
| Product Name | Plerixafor 13C6 |
|---|---|
| Alternate Names | Plerixafor Stable Isotopes, Stable Isotopes of Plerixafor |
| CAT No. | CS-EK-01123 |
| CAS No. | 110078-46-1 unlabeled |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Plerixafor |
| Canonical Smiles | C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3 |
| InchIKey | YIQPUIGJQJDJOS-UHFFFAOYSA-N |
| Inchl | InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2 |
| IUPAC | 1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
[13C6]-Plerixafor is a stable isotope-labeled version of the drug Plerixafor, which is used in the treatment of patients with non-Hodgkin's lymphoma and multiple myeloma. Plerixafor works by blocking the CXCR4 receptor, which is involved in the migration and proliferation of cancer cells. The stable isotope-labeled version of the drug is used in research studies to track the pharmacokinetics and metabolism of Plerixafor in vivo.
Chemically, [13C6]-Plerixafor is identical to the non-labeled version of the drug, except that six carbon atoms in the molecule have been replaced with the stable isotope carbon-13. This labeling does not affect the pharmacological properties of the drug, but it does allow for the drug to be tracked and quantified in biological samples using mass spectrometry.
In research studies, [13C6]-Plerixafor is typically administered to animal subjects via injection, and blood samples are taken at various time points to measure drug levels and metabolites. This information can be used to better understand the pharmacokinetics of Plerixafor, including factors such as absorption, distribution, metabolism, and excretion, which can ultimately lead to more effective dosing and treatment strategies for patients.
Overall, [13C6]-Plerixafor is a valuable tool for researchers studying the pharmacology and metabolism of Plerixafor, with the potential to improve treatment options for patients with certain types of cancer.
Get an Instant Quote
Related Compounds
Plerixafor-d4 | Plerixafor 13C6 Hydrochloride |